Neuro drugs dumped by AbbVie are now heading to Neurocrine for $100M up front
https://medcitynews.com/2021/11/neuro-drugs-dumped-by-abbvie-are-now-heading-to-neurocrine-for-100m-up-front/
https://medcitynews.com/2021/11/neuro-drugs-dumped-by-abbvie-are-now-heading-to-neurocrine-for-100m-up-front/
https://medcitynews.com/2021/11/in-competitive-market-for-msk-sword-valued-at-2-billion/
https://medcitynews.com/2021/11/athenahealth-to-change-hands-again-in-17b-deal/
https://medcitynews.com/2021/11/vifor-pharma-adds-to-chronic-kidney-disease-lineup-with-pair-of-acquisitions/
https://medcitynews.com/2021/11/unlocking-digital-msk-for-providers/
https://medcitynews.com/2021/11/everything-and-nothing-has-changed-why-vc-innovation-and-funding-in-digital-health-need-to-target-medicaid-populations/
https://medcitynews.com/2021/11/preventing-2-million-in-fines-3-things-hospitals-can-do-to-ensure-clarity-in-transparency/
https://medcitynews.com/2021/11/biomarin-pharma-sees-big-things-for-first-fda-approved-dwarfism-drug/
https://medcitynews.com/2021/11/walgreens-bets-all-its-chips-on-a-new-healthcare-strategy-will-patients-buy-in/
https://medcitynews.com/2021/11/the-missing-link-the-importance-of-patient-reported-outcomes-on-effective-clinical-decision-making/